NIPRO

Our BusinessMedical Device Business

Renal Products

Efficiency born from our top share and comprehensive system gives us the worldwide lead in dialysis therapy

NIPRO’s dialyzers hold one of the largest shares of the world market thanks to their superior efficacy in substance removal and their biocompatibility, as well as their gentleness on patients. This naturally includes the removal of β2-microglobulins, the cause of carpal tunnel syndrome often found in long-term dialysis patients, as well as the separation of uremic toxins from the high molecular weight albumin proteins and the lowering of side-effects such as itching and pain. The change in the marker elements that are a measure of biocompatibility is extremely low as well, and our products offer other special characteristics that are world-renowned. Another major feature of NIPRO dialyzers is our proprietary technology which insures that no blood remains in the dialyzer after dialysis.

NIPRO does not rest in its pursuit of technological innovation. Through the overall development and supply of various systematized devices, equipment, and medicine related to dialysis, we work to lessen the load on both patients and medical staff. We do our utmost to make dialysis treatment both safer and more effective. Improvement of treatment method is one of our goals. In regard to needle puncture, current blood access methods represent a large burden on both patients and medical personnel. More than anyone else, we are advancing the development of safer and less painful button-hole type devices. We are also developing dialyzers with improved functionality, through products that can completely control the leakage of albumin, new hemodiafiltration methods such as an enhanced internal filtration dialyzer, and a composite dialysis membrane which is completely new and different from any product seen before.

Medical Device Business Products